MUHAMMAD K SHAKEEL

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ANDERSON, SC NPI 1477558740

General Payments — all program years on this page

$4,008.65

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 203
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $460.97 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $460.9720

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $651.0534
2019 $550.8732
2020 $556.5830
2021 $466.5027
2022 $605.8327
2023 $716.8533
2024 $460.9720

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086242330 Bayer Healthcare Pharmaceuticals Inc. $19.67 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086269854 Bayer Healthcare Pharmaceuticals Inc. $17.66 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087306771 Novartis Pharmaceuticals Corporation $34.89 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087306801 Novartis Pharmaceuticals Corporation $33.34 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105450281 AstraZeneca Pharmaceuticals LP $19.63 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117681174 Amgen Inc. $21.24 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117681176 Amgen Inc. $24.94 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117681178 Amgen Inc. $21.24 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117681180 Amgen Inc. $21.24 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839693 Otsuka Pharmaceutical Development & Commercialization, Inc. $28.03 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124051952 Vifor Pharma, Inc. $15.27 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124065520 Vifor Pharma, Inc. $15.91 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135210915 Lilly USA, LLC $16.54 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141514315 CALLIDITAS THERAPEUTICS US INC. $24.64 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141517747 CALLIDITAS THERAPEUTICS US INC. $22.72 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141520493 CALLIDITAS THERAPEUTICS US INC. $24.33 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145135997 Mallinckrodt Hospital Products Inc. $26.81 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145136001 Mallinckrodt Hospital Products Inc. $22.31 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150691880 Aurinia Pharma U.S., Inc. $30.74 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154210038 Fresenius USA Marketing, Inc. $19.82 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.